
Maruo Calcium Co., Ltd.
4102.TJPXBasic MaterialsChemicals
Latest quote
¥1,444
¥0.00 · 0.00%
4102.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteMaruo Calcium Co., Ltd., a Japan-based firm, specializes in the manufacturing and sale of diverse calcium carbonate products and various other industrial raw materials. Its comprehensive product line includes multiple forms of calcium carbonate, such as colloidal, light, ground, and food-grade types. The company also supplies animal feeds, hydrated and quick lime, wet silica products, and an assortment of minerals like talc, clay, and silica powder. Additionally, Maruo Calcium imports and distributes wet silica products. These materials are widely utilized across numerous sectors, finding application in sealants, adhesives, plastisols, films, plastics, paints, inks, rubber, and as food additives, among other uses. Founded in 1926, the company, headquartered in Akashi, Japan, was originally known as Maruo Seifun Goshi Company before changing its name to Maruo Calcium Co., Ltd. in August 1963.
- Industry
- Chemicals
- Sector
- Basic Materials
- Headquarters
- JP
- CEO
- Haruo Maruo
- Listed since
- Apr 4, 2000
- Employees
- 239
Market position
Day range
Current ¥1,444
52-week range
Current ¥1,444
- Open
- ¥1,453
- Previous close
- ¥1,444
- Volume
- 300
- 0.64× average
- Average volume
- 470
- Average daily volume
- Market cap
- 3.08B JPY
- Beta
- 0.17
- Market reference 1
- 50-day average
- ¥1,441.94
- +0.14% above average
- 200-day average
- ¥1,432.07
- +0.83% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.78B JPY
- P/E (TTM)
- 8.57×
- P/B (TTM)
- 0.3×
- P/S (TTM)
- 0.24×
- EV / EBITDA
- 4.14×
- Earnings yield
- 9.75%
- Free cash flow yield
- 13.76%
- Dividend yield
- 4.16%
Profitability & efficiency
- Gross margin
- 17.58%
- Operating margin
- 1.01%
- Net margin
- 2.75%
- Return on equity
- 2.91%
- Return on assets
- 1.71%
- Return on invested capital
- 0.45%
Financial health
- Debt / equity
- 0.22×
- Current ratio
- 2.65×
- Altman Z-score
- 1.96
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12.64B JPY | 12.84B JPY | 12.89B JPY | 12.59B JPY | 11.57B JPY |
| Cost of goods sold | 10.45B JPY | 10.72B JPY | 10.65B JPY | 10.32B JPY | 9.46B JPY |
| Gross profit | 2.19B JPY | 2.12B JPY | 2.24B JPY | 2.27B JPY | 2.11B JPY |
| Research and development | — | 344.52M JPY | 319.1M JPY | 284.21M JPY | 323.17M JPY |
| Selling, general, and administrative | 2.11B JPY | 1.77B JPY | 1.78B JPY | 1.95B JPY | 1.65B JPY |
| Operating expenses | 2.11B JPY | 2.12B JPY | 2.1B JPY | 2.24B JPY | 1.97B JPY |
| Interest income | 14.27M JPY | 18.81M JPY | 16.52M JPY | 22.7M JPY | 6.38M JPY |
| Interest expense | 19.13M JPY | 14.81M JPY | 6.33M JPY | 6.34M JPY | 5.54M JPY |
| Depreciation and amortization | 588.96M JPY | 520.34M JPY | 496.66M JPY | 483.34M JPY | 589.23M JPY |
| Operating income | 82.17M JPY | 4.13M JPY | 135.77M JPY | 31.91M JPY | 136.74M JPY |
| Net income | 293.51M JPY | 148.63M JPY | 249.24M JPY | 117.14M JPY | 190.8M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 31.03
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Sep 28, 2016 | 1:5 | — | — |
Effective Sep 28, 2016
1:5
4102.T peers
Continue in GoAI
Research 4102.Tresearch.disclaimer





